Expression of ENSG00000290147 in endometrial cancer

We use cookies to enhance the usability of our website. If you continue, we'll assume that you are happy to receive all cookies. More information. Don't show this again.

ENSG00000290147

Search result

Field

Cluster

Pathway

SUMMARY

TISSUE

BRAIN

SINGLE CELL

SUBCELL

CANCER

BLOOD

CELL LINE

STRUCT & INT

ENSG00000290147

UTERINE CORPUS ENDOMETRIAL CARCINOMA (TCGA) - Interactive survival scatter plotⁱ The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red. The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off". Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation. Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient. & Survival analysisⁱ Kaplan-Meier plots summarize results from analysis of correlation between mRNA expression level and patient survival. Patients were divided based on level of expression into one of the two groups "low" (under cut off) or "high" (over cut off). X-axis shows time for survival (years) and y-axis shows the probability of survival, where 1.0 corresponds to 100 percent.
Survival analysis data not available.

ENDOMETRIOID ADENOCARCINOMA - Protein relative expression (CPTAC)

Number of samples

153

Samples

Sample ID	Sample type	nRPX
CPT0080890001	Normal	N/A
CPT0000980012	Tumor	N/A
CPT0077770003	Tumor	N/A
CPT0002080011	Tumor	N/A
CPT0077660001	Normal	N/A
CPT0066620003	Tumor	N/A
CPT0001460012	Tumor	N/A
CPT0064950001	Normal	N/A
CPT0073520003	Tumor	N/A
CPT0027130001	Normal	N/A
CPT0017870003	Tumor	N/A
CPT0080300003	Tumor	N/A
CPT0080700003	Tumor	N/A
CPT0016370003	Tumor	N/A
CPT0063250003	Tumor	N/A
CPT0016830003	Tumor	N/A
CPT0062940003	Tumor	N/A
CPT0010430003	Tumor	N/A
NX1	Normal	N/A
CPT0063670003	Tumor	N/A
NX4	Normal	N/A
CPT0023810003	Tumor	N/A
CPT0078320004	Tumor	N/A
NX6	Normal	N/A
CPT0010610003	Tumor	N/A
CPT0002450001	Normal	N/A
NX9	Normal	N/A
CPT0022530003	Tumor	N/A
CPT0093280003	Tumor	N/A
CPT0064320001	Normal	N/A
CPT0016220003	Tumor	N/A
CPT0063380003	Tumor	N/A
CPT0011000003	Tumor	N/A
CPT0010820003	Tumor	N/A
CPT0007660001	Normal	N/A
CPT0019840003	Tumor	N/A
CPT0080980003	Tumor	N/A
CPT0063090003	Tumor	N/A
CPT0002560003	Tumor	N/A
CPT0027430001	Normal	N/A
CPT0001910016	Tumor	N/A
CPT0022850001	Normal	N/A
CPT0026650003	Tumor	N/A
CPT0024130003	Tumor	N/A
CPT0073450003	Tumor	N/A
CPT0075900003	Tumor	N/A
CPT0027650003	Tumor	N/A
CPT0064210003	Tumor	N/A
CPT0026770003	Tumor	N/A
CPT0063890003	Tumor	N/A
CPT0026540001	Normal	N/A
CPT0116550004	Tumor	N/A
CPT0023630003	Tumor	N/A
CPT0116630003	Tumor	N/A
CPT0027020001	Normal	N/A
CPT0113690003	Tumor	N/A
CPT0016490003	Tumor	N/A
CPT0070260003	Tumor	N/A
CPT0073730003	Tumor	N/A
CPT0027970003	Tumor	N/A
CPT0002130003	Tumor	N/A
CPT0001140003	Tumor	N/A
CPT0097010003	Tumor	N/A
CPT0080610003	Tumor	N/A
CPT0018570003	Tumor	N/A
CPT0080880003	Tumor	N/A
CPT0016260003	Tumor	N/A
CPT0077780001	Normal	N/A
CPT0000730011	Tumor	N/A
CPT0077650003	Tumor	N/A
CPT0001470001	Normal	N/A
CPT0064930004	Tumor	N/A
CPT0073530001	Normal	N/A
CPT0027120003	Tumor	N/A
CPT0027810003	Tumor	N/A
CPT0001420009	Tumor	N/A
CPT0017930001	Normal	N/A
CPT0026270003	Tumor	N/A
CPT0022620003	Tumor	N/A
CPT0063260001	Normal	N/A
CPT0018960003	Tumor	N/A
NX12	Normal	N/A
NX17	Normal	N/A
NX13	Normal	N/A
NX14	Normal	N/A
NX10	Normal	N/A
NX16	Normal	N/A
NX18	Normal	N/A
NX11	Normal	N/A
NX15	Normal	N/A
CPT0076160003	Tumor	N/A
CPT0007100003	Tumor	N/A
NX2	Normal	N/A
CPT0020530003	Tumor	N/A
CPT0078360001	Normal	N/A
CPT0076680003	Tumor	N/A
CPT0063790003	Tumor	N/A
CPT0002430011	Tumor	N/A
CPT0064150004	Tumor	N/A
CPT0027320003	Tumor	N/A
CPT0093290000	Normal	N/A
CPT0080030003	Tumor	N/A
CPT0064290004	Tumor	N/A
CPT0002630003	Tumor	N/A
CPT0080400003	Tumor	N/A
CPT0011020003	Normal	N/A
CPT0079570003	Tumor	N/A
CPT0007600003	Tumor	N/A
CPT0026430003	Tumor	N/A
CPT0080990001	Normal	N/A
CPT0063110001	Normal	N/A
CPT0026030004	Tumor	N/A
CPT0070380004	Tumor	N/A
CPT0026660001	Normal	N/A
CPT0078880003	Tumor	N/A
CPT0079650003	Tumor	N/A
CPT0002210011	Tumor	N/A
CPT0075940001	Normal	N/A
NX7	Normal	N/A
CPT0027520003	Tumor	N/A
CPT0026780001	Normal	N/A
CPT0097730003	Tumor	N/A
CPT0063900001	Normal	N/A
CPT0002500011	Tumor	N/A
CPT0116570003	Normal	N/A
CPT0075380003	Tumor	N/A
NX3	Normal	N/A
CPT0076500003	Tumor	N/A
NX5	Normal	N/A
CPT0018790003	Tumor	N/A
NX8	Normal	N/A
CPT0078610003	Tumor	N/A
CPT0010260003	Tumor	N/A
CPT0001850012	Tumor	N/A
CPT0078710004	Tumor	N/A
CPT0009980003	Tumor	N/A
CPT0027420003	Tumor	N/A
CPT0021650003	Tumor	N/A
CPT0022830003	Tumor	N/A
CPT0002010011	Tumor	N/A
CPT0073460001	Normal	N/A
CPT0001300009	Tumor	N/A
CPT0064240001	Normal	N/A
CPT0026530003	Tumor	N/A
CPT0023640001	Normal	N/A
CPT0070330004	Tumor	N/A
CPT0016530001	Normal	N/A
CPT0015520003	Tumor	N/A
CPT0097710003	Tumor	N/A
CPT0000820012	Tumor	N/A
CPT0076860003	Tumor	N/A
CPT0016940003	Tumor	N/A
CPT0080620001	Normal	N/A
Show allShow less

UTERINE CORPUS ENDOMETRIAL CARCINOMA - Protein relative expression (CPTAC)

Number of samples

160

Samples

Sample ID	Sample type	nRPX
CPT0128960003	Tumor	N/A
CPT0244510003	Tumor	N/A
CPT0197250003	Tumor	N/A
CPT0100100003	Tumor	N/A
CPT0117510003	Tumor	N/A
CPT0265300003	Tumor	N/A
CPT0181670008	Tumor	N/A
CPT0187960004	Tumor	N/A
CPT0111950003	Tumor	N/A
CPT0092690003	Tumor	N/A
CPT0095280003	Tumor	N/A
NX027	Normal	N/A
CPT0115470003	Tumor	N/A
CPT0181320003	Tumor	N/A
CPT0116010004	Tumor	N/A
CPT0182340004	Tumor	N/A
NX026	Normal	N/A
CPT0097440003	Tumor	N/A
CPT0095230003	Tumor	N/A
CPT0117010004	Tumor	N/A
CPT0095100003	Tumor	N/A
CPT0095190003	Tumor	N/A
CPT0108750003	Tumor	N/A
CPT0114340003	Tumor	N/A
NX021	Normal	N/A
CPT0203040008	Tumor	N/A
CPT0115000004	Tumor	N/A
CPT0133600003	Tumor	N/A
CPT0113910003	Tumor	N/A
CPT0091910003	Tumor	N/A
CPT0182070004	Tumor	N/A
NX031	Normal	N/A
CPT0086490003	Tumor	N/A
CPT0116140004	Tumor	N/A
NX020	Normal	N/A
CPT0244470003.1	Tumor	N/A
CPT0174890008	Tumor	N/A
CPT0092860003	Tumor	N/A
CPT0112910003	Tumor	N/A
CPT0134500003	Tumor	N/A
CPT0116340004	Tumor	N/A
NX022	Normal	N/A
CPT0203250008	Tumor	N/A
CPT0188370003	Tumor	N/A
CPT0100010003	Tumor	N/A
CPT0113430004	Tumor	N/A
CPT0186900008	Tumor	N/A
CPT0181610003	Tumor	N/A
CPT0244470003	Tumor	N/A
CPT0288750003	Tumor	N/A
CPT0104690003	Tumor	N/A
CPT0186560008	Tumor	N/A
CPT0161590008	Tumor	N/A
CPT0186010004	Tumor	N/A
CPT0083580003	Tumor	N/A
CPT0099050003	Tumor	N/A
NX036	Normal	N/A
CPT0117560003	Tumor	N/A
CPT0238260003	Tumor	N/A
CPT0117300003	Tumor	N/A
CPT0116250004	Tumor	N/A
CPT0113060003	Tumor	N/A
CPT0092460003	Tumor	N/A
NX024	Normal	N/A
NX033	Normal	N/A
CPT0137140008	Tumor	N/A
CPT0117440003	Tumor	N/A
CPT0225010003	Tumor	N/A
CPT0096010003	Tumor	N/A
CPT0186720008	Tumor	N/A
NX032	Normal	N/A
CPT0095880003	Tumor	N/A
CPT0188190004	Tumor	N/A
CPT0091720003	Tumor	N/A
CPT0188270004	Tumor	N/A
CPT0134310008	Tumor	N/A
CPT0188030003	Tumor	N/A
CPT0086090003	Tumor	N/A
CPT0181540008	Tumor	N/A
CPT0129520003	Tumor	N/A
CPT0158520008	Tumor	N/A
CPT0182290003	Tumor	N/A
CPT0188710003	Tumor	N/A
CPT0182020004	Tumor	N/A
CPT0133400008	Tumor	N/A
CPT0115530003	Tumor	N/A
CPT0087260003	Tumor	N/A
NX028	Normal	N/A
CPT0182380004	Tumor	N/A
CPT0188610003	Tumor	N/A
CPT0265110003	Tumor	N/A
CPT0113330003	Tumor	N/A
CPT0275270003.1	Tumor	N/A
CPT0116710003	Tumor	N/A
CPT0111880003	Tumor	N/A
CPT0128770003	Tumor	N/A
CPT0117370004	Tumor	N/A
CPT0097300003	Tumor	N/A
CPT0126000003	Tumor	N/A
CPT0288830003	Tumor	N/A
CPT0172200008	Tumor	N/A
CPT0088140003	Tumor	N/A
CPT0188100004	Tumor	N/A
CPT0117230003	Tumor	N/A
CPT0136280003	Tumor	N/A
CPT0226810003	Tumor	N/A
CPT0114100003	Tumor	N/A
CPT0093170003	Tumor	N/A
CPT0104820003	Tumor	N/A
CPT0159220008	Tumor	N/A
NX037	Normal	N/A
CPT0128370003	Tumor	N/A
CPT0111810003	Tumor	N/A
CPT0275270003	Tumor	N/A
CPT0129080003	Tumor	N/A
CPT0098920003	Tumor	N/A
CPT0188480004	Tumor	N/A
CPT0181960004	Tumor	N/A
CPT0181750004	Tumor	N/A
NX035	Normal	N/A
CPT0248000003	Tumor	N/A
CPT0127700003	Tumor	N/A
CPT0247880003	Tumor	N/A
CPT0247910003	Tumor	N/A
NX025	Normal	N/A
CPT0129640003	Tumor	N/A
CPT0133770008	Tumor	N/A
CPT0172460008	Tumor	N/A
CPT0182150003	Tumor	N/A
CPT0247970003	Tumor	N/A
CPT0112780003	Tumor	N/A
CPT0098270003	Tumor	N/A
CPT0089600003	Tumor	N/A
CPT0234080003	Tumor	N/A
CPT0113850003	Tumor	N/A
CPT0226860003	Tumor	N/A
CPT0091990003	Tumor	N/A
CPT0182210004	Tumor	N/A
CPT0111720003	Tumor	N/A
CPT0095130004	Tumor	N/A
CPT0091780003	Tumor	N/A
NX038	Normal	N/A
CPT0127610003	Tumor	N/A
CPT0116940003	Tumor	N/A
NX019	Normal	N/A
NX030	Normal	N/A
CPT0128610003	Tumor	N/A
NX029	Normal	N/A
CPT0190700008	Tumor	N/A
CPT0203150008	Tumor	N/A
CPT0099910003	Tumor	N/A
CPT0181810004	Tumor	N/A
NX023	Normal	N/A
CPT0159110003	Tumor	N/A
CPT0171090008	Tumor	N/A
CPT0196790004	Tumor	N/A
CPT0127980003	Tumor	N/A
CPT0211120004	Tumor	N/A
CPT0247940003	Tumor	N/A
NX034	Normal	N/A
Show allShow less

ENDOMETRIAL CANCER - Protein expressionⁱ A mouse-over function shows sample information and annotation data. Click on an image to view it in a full screen mode. Samples can be filtered based on level of antibody staining by selecting one or several of the following categories: high, medium, low and not detected. The assay and annotation is described here. Note that samples used for immunohistochemistry by the Human Protein Atlas do not correspond to samples in the TCGA dataset.

Antibody stainingⁱ Antibody staining in the annotated cell types in the current human tissue is reported as not detected, low, medium, or high, based on conventional immunohistochemistry profiling in selected tissues. This score is based on the combination of the staining intensity and fraction of stained cells. Each image is clickable and will lead to virtual microscopy that enables deeper exploration of all samples and also displays staining intensity scores, fraction scores and subcellular localization as well as patient and tissue information for each sample.	Antibody HPA005561	Antibody HPA075056
Staining
High
Medium
Low
Not detected
Intensity
Strong
Moderate
Weak
Negative
Quantity
>75%
75%-25%
<25%
None
Location
Nuclear
Cytoplasmic/membranous
Cytoplasmic/membranous,nuclear
None
Adenocarcinoma, NOS
Adenocarcinoma, NOS Adenocarcinoma, metastatic, NOS

Contact

The Project

The Human Protein Atlas

The Human Protein Atlas project is funded
by the Knut & Alice Wallenberg Foundation.

contact@proteinatlas.org